Tom Thomson

935 total citations
23 papers, 730 citations indexed

About

Tom Thomson is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Tom Thomson has authored 23 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cancer Research. Recurrent topics in Tom Thomson's work include HER2/EGFR in Cancer Research (5 papers), Cancer and Skin Lesions (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Tom Thomson is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cancer and Skin Lesions (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Tom Thomson collaborates with scholars based in Canada, United Kingdom and France. Tom Thomson's co-authors include Steven Tang, Don R. Phillips, Brenda Lomax, C. Blake Gilks, Adam P. Curnock, Christopher Yea, Robert Westwood, Richard A. Williamson, Suresh Jivan Gadher and Philip B. Clement and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The American Journal of Human Genetics.

In The Last Decade

Tom Thomson

23 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Thomson Canada 15 227 206 124 115 114 23 730
Amanda M. Holland United States 14 328 1.4× 283 1.4× 41 0.3× 51 0.4× 87 0.8× 25 1.3k
Elvis Terci Valera Brazil 18 725 3.2× 275 1.3× 88 0.7× 186 1.6× 86 0.8× 108 1.4k
Sébastien Malinge United States 17 631 2.8× 188 0.9× 89 0.7× 191 1.7× 140 1.2× 33 1.4k
Terri Rice United States 21 448 2.0× 248 1.2× 45 0.4× 243 2.1× 103 0.9× 42 1.2k
Valeria Cancila Italy 17 526 2.3× 402 2.0× 44 0.4× 243 2.1× 50 0.4× 49 1.3k
Laureano Simón Spain 13 207 0.9× 113 0.5× 22 0.2× 58 0.5× 46 0.4× 29 660
Maria Daniotti Italy 10 607 2.7× 335 1.6× 174 1.4× 204 1.8× 65 0.6× 11 1.2k
Erin Gatza United States 13 318 1.4× 201 1.0× 46 0.4× 48 0.4× 45 0.4× 18 967
Synnöve Staff Finland 20 454 2.0× 429 2.1× 127 1.0× 172 1.5× 158 1.4× 48 1.2k
Erik Thorud Norway 22 289 1.3× 405 2.0× 30 0.2× 348 3.0× 42 0.4× 50 1.2k

Countries citing papers authored by Tom Thomson

Since Specialization
Citations

This map shows the geographic impact of Tom Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Thomson more than expected).

Fields of papers citing papers by Tom Thomson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Thomson. The network helps show where Tom Thomson may publish in the future.

Co-authorship network of co-authors of Tom Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Thomson. A scholar is included among the top collaborators of Tom Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Thomson. Tom Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yaoqing, Martin Jones, Tony Ng, et al.. (2017). Carcinoma Ex Pleomorphic Adenoma: Case Report and Options for Systemic Therapy. Current Oncology. 24(3). 251–254. 11 indexed citations
2.
Sheffield, Brandon S., Zuzana Kos, Karama Asleh, et al.. (2016). Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor. Breast Cancer Research and Treatment. 155(3). 483–490. 27 indexed citations
3.
O’Malley, Frances P., Tom Thomson, Jim A. Julian, et al.. (2008). HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab.. Archives of Pathology & Laboratory Medicine. 132(1). 61–5. 23 indexed citations
4.
Hanna, Wedad, F. O’Malley, Penny J. Barnes, et al.. (2007). Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer. Current Oncology. 14(4). 149–153. 50 indexed citations
5.
Robinson, Andrew, Dmitry Turbin, Tom Thomson, et al.. (2006). Molecular Predictive Factors in Patients Receiving Trastuzumab-Based Chemotherapy for Metastatic Disease. Clinical Breast Cancer. 7(3). 254–261. 22 indexed citations
6.
Cheifetz, Rona, et al.. (2005). Can cytology accurately predict benign follicular nodules?. The American Journal of Surgery. 189(5). 592–595. 53 indexed citations
7.
Rajcan‐Separovic, Evica, Glenda Hendson, Steven Tang, et al.. (2002). Interphase fluorescence in situ hybridization and DNA flow cytometry analysis of medulloblastomas with a normal karyotype. Cancer Genetics and Cytogenetics. 133(1). 94–97. 3 indexed citations
8.
Thomson, Tom, et al.. (2002). In Vitro and In Vivo Inhibition of Immunoglobulin Secretion by the Immunosuppressive Compound HR325 is Reversed by Exogenous Uridine. Scandinavian Journal of Immunology. 56(1). 35–42. 3 indexed citations
9.
10.
Lomax, Brenda, et al.. (2000). Comparative Genomic Hybridization in Combination with Flow Cytometry Improves Results of Cytogenetic Analysis of Spontaneous Abortions. The American Journal of Human Genetics. 66(5). 1516–1521. 126 indexed citations
11.
Nimmo, Michael, et al.. (2000). Prognostic Factors in Paget’s Disease of the Vulva: A Study of 21 Cases. Obstetrical & Gynecological Survey. 55(4). 218–219. 5 indexed citations
12.
Thomson, Tom, Douglas E. Horsman, & Terry C. Bainbridge. (1999). Cytogenetic and cytologic features of chondroid lipoma of soft tissue.. PubMed. 12(1). 88–91. 25 indexed citations
13.
Nimmo, Michael, et al.. (1999). Prognostic Factors in Pagetʼs Disease of the Vulva. International Journal of Gynecological Pathology. 18(4). 351–359. 75 indexed citations
14.
Curnock, Adam P., P.A. Robson, Christopher Yea, et al.. (1997). Potencies of Leflunomide and HR325 as Inhibitors of Prostaglandin Endoperoxide H Synthase-1 and -2: Comparison with Nonsteroidal Anti-Inflammatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 282(1). 339–347. 14 indexed citations
15.
McLaren, Duncan B., Tom Pickles, Tom Thomson, & Peggy L. Olive. (1997). Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay. Radiotherapy and Oncology. 45(2). 175–182. 19 indexed citations
16.
Williamson, Richard A., Christopher Yea, P.A. Robson, et al.. (1995). Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound. Journal of Biological Chemistry. 270(38). 22467–22472. 173 indexed citations
17.
Seed, Michael, Chi Yuen Cheung, Tom Thomson, et al.. (1993). Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391.. Annals of the Rheumatic Diseases. 52(1). 37–43. 25 indexed citations
18.
Gardner, Colin, et al.. (1991). Relationship between structure and efficacy at central benzodiazepine receptors for a series of imidazopyrimidines and imidazoquinolines. Drug Development Research. 22(4). 309–320. 10 indexed citations
19.
Thomson, Tom, et al.. (1990). Differential interactions of Ro 15-4513 with benzodiazepines, ethanol and pentobarbital. European Journal of Pharmacology. 180(2-3). 283–290. 6 indexed citations
20.
McKillop, J. H., et al.. (1978). LARYNGEAL MALIGNANCY FOLLOWING IODINE-125 THERAPY FOR THYROTOXICOSIS. The Lancet. 312(8101). 1177–1179. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda M. Holland Breakdown of academic impact, for papers by Elvis Terci Valera Breakdown of academic impact, for papers by Sébastien Malinge Breakdown of academic impact, for papers by Terri Rice Breakdown of academic impact, for papers by Valeria Cancila Breakdown of academic impact, for papers by Laureano Simón Breakdown of academic impact, for papers by Maria Daniotti Breakdown of academic impact, for papers by Erin Gatza Breakdown of academic impact, for papers by Synnöve Staff Breakdown of academic impact, for papers by Erik Thorud
Rankless by CCL
2026